Evidence map›Paper›PMID 31388965›Full record

SynthesisJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2021

Sodium fluoride in cardiovascular disorders: A systematic review.

Beatriz Isabel Silva Mendes, Manuel Oliveira-Santos, Maria João Vidigal Ferreira

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2022: positron emission tomography, computed tomography, and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Review
  2. Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  3. Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  4. Review
  5. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  6. [Frontiers in medicine · 2021
    Article
  7. Trace Elements, PPARs, and Metabolic Syndrome.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Beatriz Isabel Silva MendesFaculdade de Medicina da Universidade de Coimbra, Azinhaga de Santa Comba - Celas PT, 3000-548, Coimbra, Portugal. mendes.bea@hotmail.com.
Manuel Oliveira-SantosFaculdade de Medicina da Universidade de Coimbra, Azinhaga de Santa Comba - Celas PT, 3000-548, Coimbra, Portugal.
Maria João Vidigal FerreiraFaculdade de Medicina da Universidade de Coimbra, Azinhaga de Santa Comba - Celas PT, 3000-548, Coimbra, Portugal.
Hospitais da Universidade de Coimbra · PTUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background18-Fluorine sodium fluoride is a well-known radiotracer used for bone metastasis diagnosis. Its uptake correlation with cardiovascular (CV) risk was primarily suggested in oncological patients. Moreover, as a specific marker of microcalcification, it seems to correlate with CV disease progression and plaque instability. METHODS AND

resultsOur purpose was to systematically review clinical studies that characterized the use of this marker in CV conditions. In atherosclerosis, most studies report a positive correlation with the burden of CV risk factors and vascular calcification. A higher uptake was found in culprit plaques/rupture sites in coronary and carotid arteries and it was also linked to high-risk features in histology and intravascular imaging analysis of the plaques. In aortic stenosis, this tracer displayed an increasing uptake with disease severity.

conclusionsSodium fluoride positron emission tomography is a promising non-invasive technique to identify high-risk plaques, which sets ground to a potential use of this tracer in evaluating atherosclerotic disease progression and degenerative changes in aortic valve stenosis. Nevertheless, there is a need for further prospective evidence that demonstrates this technique's value in predicting clinical events, adjusting treatment strategies, and improving patient outcomes.

Indexed as

Fluorine RadioisotopesPositron-Emission TomographySodium FluorideCardiovascular DiseasesHumansFluorine-18Fluorine RadioisotopesSodium FluorideatherosclerosisCADimage analysismolecular imaging agentsPETvalvular heart disease

Identifiers

PMID31388965
OpenAlexW2965657359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.